Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • Pavolga
    Member
    • Feb 2010
    • 31

    #1

    Workshop in SF in June: Implementing NGS for Clinical Diagnostics

    Implementing Next-Generation Sequencing for Clinical Diagnostics

    A short course at TCGC: The Clinical Genome Conference
    Monday, June 24, 2013, 2:00-5:00 pm | Hotel Kabuki | San Francisco, CA



    The rapid evolution of next-generation sequencing and the resulting move into routine clinical practice requires arguably as much skill in navigating bureaucracy as mapping and interpreting base pairs. Significant challenges for clinical diagnostics include the rapid evolution of platforms, protocols, kits, and reagents as well as genome analysis, interpretation, and ethics. This short course provides practical information on implementing clinical sequencing, genomic data analysis and interpretation, ethics, CLIA certification and CAP standards. This short course has been created in collaboration between Cambridge Healthtech Institute and the College of American Pathologists.

    INSTRUCTORS:

    Development of CAP/CLIA Standards as an Essential Framework for Clinical Testing Using Next-Generation Sequencing
    Nazneen Aziz, Ph.D., Director of Molecular Medicine, Transformation Program Office, College of American Pathologists

    Data Interpretation and Ethics in Clinical Genomic Sequencing
    Wayne W. Grody, M.D., Ph.D., Professor, Medical Genetics and Molecular Diagnostics; Director, Clinical Genomics Center, School of Medicine, University of California, Los Angeles

    Additional Instructors to be Announced

    TCGC: The Clinical Genome Conference Agenda http://www.clinicalgenomeconference.com/

    Registration information: https://chidb.com/register/2013/clg/reg.asp

Latest Articles

Collapse

  • SEQadmin2
    Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
    by SEQadmin2



    Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

    Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
    ...
    10-14-2026, 09:55 AM
  • SEQadmin2
    New Genomics Technologies Take Aim at Long-Standing Limits
    by SEQadmin2


    Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

    We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
    ...
    09-28-2026, 10:25 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, 10-22-2026, 11:13 AM
0 responses
61 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-22-2026, 10:48 AM
0 responses
44 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-15-2026, 10:52 AM
0 responses
77 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-14-2026, 05:39 AM
0 responses
74 views
0 reactions
Last Post SEQadmin2  
Working...